ArticleAlzheimer's & dementia (New York, N. Y.)2019

Hematologic safety of chronic brain-penetrating erythropoietin dosing in APP/PS1 mice.

Jiahong Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.